These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15762661)

  • 21. Zeta-potentials of alginate-PLL capsules: a predictive measure for biocompatibility?
    de Vos P; de Haan BJ; Kamps JA; Faas MM; Kitano T
    J Biomed Mater Res A; 2007 Mar; 80(4):813-9. PubMed ID: 17058213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time-dependent alginate/polyvinyl alcohol hydrogels as injectable cell carriers.
    Cho SH; Lim SM; Han DK; Yuk SH; Im GI; Lee JH
    J Biomater Sci Polym Ed; 2009; 20(7-8):863-76. PubMed ID: 19454157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biocompatibility and function of microencapsulated pancreatic islets.
    Figliuzzi M; Plati T; Cornolti R; Adobati F; Fagiani A; Rossi L; Remuzzi G; Remuzzi A
    Acta Biomater; 2006 Mar; 2(2):221-7. PubMed ID: 16701881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microcapsules made by enzymatically tailored alginate.
    Strand BL; Mørch YA; Syvertsen KR; Espevik T; Skjåk-Braek G
    J Biomed Mater Res A; 2003 Mar; 64(3):540-50. PubMed ID: 12579569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraperitoneal stability of alginate-polyornithine microcapsules in rats: an FTIR and SEM analysis.
    Thanos CG; Bintz BE; Bell WJ; Qian H; Schneider PA; MacArthur DH; Emerich DF
    Biomaterials; 2006 Jul; 27(19):3570-9. PubMed ID: 16497374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and characterization of alginate/poly-L-ornithine/alginate microcapsules for local immunosuppression.
    Leung A; Lawrie G; Nielsen LK; Trau M
    J Microencapsul; 2008 Sep; 25(6):387-98. PubMed ID: 18465312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo biocompatibility and stability of a substrate-supported polymerizable membrane-mimetic film.
    Wilson JT; Cui W; Sun XL; Tucker-Burden C; Weber CJ; Chaikof EL
    Biomaterials; 2007 Feb; 28(4):609-17. PubMed ID: 17055571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulating the alginate-polyornithine biocapsule for prolonged stability: evaluation of composition and manufacturing technique.
    Thanos CG; Calafiore R; Basta G; Bintz BE; Bell WJ; Hudak J; Vasconcellos A; Schneider P; Skinner SJ; Geaney M; Tan P; Elliot RB; Tatnell M; Escobar L; Qian H; Mathiowitz E; Emerich DF
    J Biomed Mater Res A; 2007 Oct; 83(1):216-24. PubMed ID: 17607741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of encapsulated embryonic stem cells after transplantation.
    Dean SK; Yulyana Y; Williams G; Sidhu KS; Tuch BE
    Transplantation; 2006 Nov; 82(9):1175-84. PubMed ID: 17102769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving stability and biocompatibility of alginate/chitosan microcapsule by fabricating bi-functional membrane.
    Zheng G; Liu X; Wang X; Chen L; Xie H; Wang F; Zheng H; Yu W; Ma X
    Macromol Biosci; 2014 May; 14(5):655-66. PubMed ID: 24436207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of Poly-L-Ornithine-coated alginate microcapsules.
    Darrabie MD; Kendall WF; Opara EC
    Biomaterials; 2005 Dec; 26(34):6846-52. PubMed ID: 15955558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained and therapeutic levels of human factor IX in hemophilia B mice implanted with microcapsules: key role of encapsulated cells.
    Wen J; Vargas AG; Ofosu FA; Hortelano G
    J Gene Med; 2006 Mar; 8(3):362-9. PubMed ID: 16311997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adsorption of human immunoglobulin to implantable alginate-poly-L-lysine microcapsules: effect of microcapsule composition.
    Tam SK; de Haan BJ; Faas MM; Hallé JP; Yahia L; de Vos P
    J Biomed Mater Res A; 2009 Jun; 89(3):609-15. PubMed ID: 18435412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules.
    De Vos P; De Haan B; Van Schilfgaarde R
    Biomaterials; 1997 Feb; 18(3):273-8. PubMed ID: 9031730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of alginate purification methods: effect on polyphenol, endotoxin, and protein contamination.
    Dusseault J; Tam SK; Ménard M; Polizu S; Jourdan G; Yahia L; Hallé JP
    J Biomed Mater Res A; 2006 Feb; 76(2):243-51. PubMed ID: 16265647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of implantation site on the biocompatibility and survival of alginate encapsulated pig islets in rats.
    Dufrane D; Steenberghe Mv; Goebbels RM; Saliez A; Guiot Y; Gianello P
    Biomaterials; 2006 Jun; 27(17):3201-8. PubMed ID: 16497373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of inflammatory reaction in the use of purified alginate microcapsules.
    Kim AR; Hwang JH; Kim HM; Kim HN; Song JE; Yang YI; Yoon KH; Lee D; Khang G
    J Biomater Sci Polym Ed; 2013; 24(9):1084-98. PubMed ID: 23683040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress technology in microencapsulation methods for cell therapy.
    Rabanel JM; Banquy X; Zouaoui H; Mokhtar M; Hildgen P
    Biotechnol Prog; 2009; 25(4):946-63. PubMed ID: 19551901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Encapsulation of recombinant cells with a novel magnetized alginate for magnetic resonance imaging.
    Shen F; Li AA; Gong YK; Somers S; Potter MA; Winnik FM; Chang PL
    Hum Gene Ther; 2005 Aug; 16(8):971-84. PubMed ID: 16076255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative in vitro study on cytotoxicity, antimicrobial activity, and binding capacity for pathophysiological factors in chronic wounds of alginate and silver-containing alginate.
    Wiegand C; Heinze T; Hipler UC
    Wound Repair Regen; 2009; 17(4):511-21. PubMed ID: 19614916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.